Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder – An 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients
References (43)
- et al.
Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs
Gen Hosp Psychiatry
(1990) Alternatives to placebo-controlled trials in psychiatry. ECNP Consensus Meeting, September 26, 1996, Amsterdam. European College of Neuropsychopharmacology
Eur Neuropsychopharmacol
(1999)Kava: An overview
J Ethnopharmacol
(1992)- et al.
Opipramol in the climacteric syndrome. A double-blind, placebo-controlled trial
Maturitas
(1983) - et al.
Opipramol for the treatment of somatoform disorders, results from a placebo-controlled trial
Eur Neuropsychopharmacol
(2000) - et al.
Venlafaxine extended release (ER) in the treatment of generalized anxiety disorder. Twenty-four-week placebo-controlled dose-ranging study
Br J Psychiatry
(2001) Buspirone HCl
Kava kava in the treatment of generalized anxiety disorder, simple phobia and specific social phobia
Phytother Res
(2001)Kava kava in the treatment of generalized anxiety disorder, simple phobia and specific social phobia
Phytother Res
(2001)- RJ Boerner (2002a) Angststörungen. In: Neuro—Psychopharmaka, vol. 3, 2nd ed. (eds Riederer P et. al.). Springer, Wien...
Generalized anxiety disorder: issues in epidemiology
J Clin Psychiatry
(1996)
Pharmacology of Kava — 2
Psychopharmacol Bull
(1967)
Der Fragebogen Alltagsleben — ein Verfahren zur Erfassung der gesundheitsbezogenen Lebensqualität
Zeitschrift für Medizinische Psychologie
(1993)
Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder
J Clin Psychiatry
(1999)
Hepatitis associated with Kava, a herbal remedy for anxiety
BMJ
(2001)
Buspirone: an updated review of its clinical pharmacology and therapeutic applications
CNS Drugs
(1997)
On the Development of a Standardized Sleep Inventory for the Assessment of Sleep
In der Diskussion: Kava-Kava — Schädliche Stoffe im Aceton-Extrakt?
Dtsch Apoth Ztg
(2000)
Cited by (0)
Copyright © 2003 Urban & Fischer Verlag. Published by Elsevier GmbH All rights reserved.